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Abstract 
Background: Vast variety of intermediate factors including cell cycle regulators, growth factors, transcription 
factors, and signaling pathways are involved in hematopoietic stem cell (HSC) commitment and differentiation 
into distinct lineages. VHL, Ecad, and RUNX3 are among these. Epigenetics is currently introduced as a 
potential mechanism to control the gene regulation. The aim of this study is to reveal the correlation between 
the expression level and methylation pattern of mentioned genes after in vitro differentiation of cord blood 
HSCs into erythroid lineage mediated by erythropoietin. 
Materials and Methods: After isolation and expansion, the CD34+ cord blood stem cells were divided into 
two parts. The first part was used to extract the DNA and RNA and the second to differentiate into erythroid 
lineage. Methylation specific PCR (MSP) and Real-time PCR were used to determine the methylation status 
and expression levels of the genes, respectively. 
Results: Although the significant upregulation observed for VHL and Ecad genes and a down-regulation for 
RUNX3 gene after differentiation, no remarkable changes were seen in methylation pattern compared with 
cord blood HSCs by MSP technique. 
Conclusion: It is appearing that methylation pattern in promoter region has not an effective role in expression 
of VHL, Ecad, and RUNX3. Moreover, considering the inability of MSP method to detect subtle differences in 
methylation level a more sensitive method is needed to distinguish the methylation levels of these genes before 
and after erythroid differentiation. 
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Introduction 
Currently abundance of knowledge on fundamental 
principles of cell biology and evolutionary 
mechanisms of tissues especially about gene 
expression has been gained
1
. Differentiation of a 
primary stem cell into distinct cell lineages is 
regulated by highly complicated pathways such as 
cytokines, transcription factors, cell cycle regulators, 
proliferation, apoptosis, and a variety of signaling 
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pathways
2
. Three of these key regulators are briefly 
introduced bellow. 
Von Hippel Lindau (VHL) gene encodes Von Hippel 
Lindau protein which consists of three subunits. VLH 
protein degenerates the HIF protein by 
ubiquitination. HIF is a specific transcription factor 
for EPO gene especially in renal cells in hypoxia 
condition. VHL is also a tumor suppressor agent and 
a cell cycle regulator. This factor accelerates the 
angiogenesis by upregulation of VEGF (Vascular 
Endothelial Growth Factor) and regulates the cell 
cycle progression by suppression of mTOR gene
2
. 
Runt-Related Transcription Factor 3 (RUNX-3) is 
involved in cell cycle regulation, and differentiation. 
This factor is also a tumor suppressor. 
Downregulation of RUNX3 is extensively reported in 
malignancies
3
. 
Calcium Dependent Adhesion E Gene (E-cad) codes 
for Ecad protein which has an essential role in 
intracellular adhesions thereby it affects the 
evolutionary processes and differentiation
4
. 
Currently emerging evidences are presenting the 
epigenetics as an inevitable contributor in regulation 
of cell differentiation which affects proliferation and 
differentiation of many cell lineages in all the 
evolutionary steps. Epigenetics is defined as the 
alteration in gene expression as well as mitotic status 
without any changes in nucleotide sequences
5-7
. 
DNA methylation is one of the well studied 
epigenetic mechanisms, which can regulate the gene 
expression
8
. 
Although there are much of ambiguities on details of 
evolution and differentiation mechanisms, extensive 
studies on transcription factors, tumor suppressors, 
and cell cycle regulators have enlighten many aspects 
of the issue. The factors selected for present study 
have essential role in hematopoietic stem cell (HSC) 
differentiation, moreover considering their promoter 
structure these genes are suitable candidates to be 
evaluated regarding promoter methylation during 
differentiation.  
Since no descriptive study has been accomplished on 
methylation status and expression levels of VHL, 
Ecad and RUNX3 genes, we provided beneficial 
information on this issue as well as presented the 
possible correlation between the methylation and 
expression level by comparing these two parameters in 
CD4+ cord blood stem cells (CB-HSCs) and 
erythropoietin (EPO) associated differentiated cells. 
Methods 
Isolation and expansion of CD34+ CB-HSCs 
Cord blood bags were provided from Sarem hospital 
(Tehran, Iran) and Tehran Blood Transfusion 
Organization. The CD34+, CB-HSCs were isolated 
from cord blood using MACS (Monoclonal Antibody 
Cell Sorting) method and Indirect CD34+ MicroBead 
Kit. The cells were then cultured in Stem Span 
medium enriched by Flt3, TPO, and SCF growth 
factors to be expanded.  
Induction of erythroid differentiation 
Pure and expanded CD34+ cells were used to be 
differentiated into erythroid lineage by EPO. 
To differentiate the CB-HSCs into erythroid lineage 
by EPO, 500µl of prepared IMDM medium enriched 
by EPO, SCF and FBS were used per 100,000 cells. 
EPO was added by the final concentration of 
100ng/ml. the medium was replaced each 48 hours and 
after 7 days. The cells were evaluated regarding the 
successful differentiation.   
Confirmation of erythroid differentiation 
Using specific primers for CD71 and CD 235 genes 
(as erythroid specific markers) polymerase chain 
reaction was performed to ensure the expression of the 
genes. It should be noted that CD71 and CD 235 
cDNAs were used in this step to evaluate the gene 
expression. The products were resolved on 1.5% 
agarose gel. We also conducted flow cytometry 
analysis to confirm erythroid differentiation using 
FITC-labeled monoclonal anti-CD71.  
DNA and RNA isolation and cDNA synthesis 
DNA was isolated from either CD-HSCs or 
differentiated cells to be used in MSP reaction using 
DNA extraction Kit (Qiagen) according to the 
manufacture procedure. Total RNA was extracted 
using RNase Mini Plus Kit (Qiagen) and cDNA was 
synthesized using cDNA synthesis kit (Fermantase). 
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Bisulfite treatment 
DNA from pre and post differentiation stages were 
treated with bisulfite using EpiTect® Bisulfite Kit 
(Qiagen) and stored in -20C. DNA treated with SssI 
was used as positive control in MSP reaction. 
Untreated DNA was applied as negative control.  
Real-time PCR 
cDNA from CB-HSCs and differentiated cells were 
used in Real-time PCR reaction. ABI 7500 device 
and CYBER Green were applied as Real-time PCR 
instrument and nucleic acid stain, respectively, and 
results were interpreted using Pfaffl calculations. 
GAPDH was selected as internal control of the 
genes. The primer sequences were those which 
previously described by the same author
9
. 
Methylation specific PCR 
DNA from both CB-HSCs and EPO mediated 
differentiated cells were applied in MSP reaction to 
evaluate the methylation pattern. Specific primers for 
either methyalted or unmethylated forms were used 
which have been described in details previously by 
the same author
9
. 
Results 
To determine successful erythroid differentiation we 
performed both PCR and flow cytometry analysis. 
Using CD71 and CD 235 cDNAs in PCR reaction 
revealed remarkable upregulation of these genes in 
EPO mediated differentiated cells, which suggests a 
high efficacy of EPO to differentiate the CB-HSCs 
into erythroid lineage in vitro (Figure1).  
The flow cytometry results also indicated that CD71 
surface marker is well expressed on EPO associated 
differentiated cells. These results showed 81% 
expression of CD71 surface marker on differentiated 
cells compared with CB-HSCs (Figure 2). 
VHL, Ecad, were upregulated and RUNX3 gene was 
downregulated after erythroid differentiation 
 Using Real–time PCR method we observed significant 
upregulation for VHL and Ecad and a downregulation 
for RUNX3 gene after differentiation by EPO. VHL, 
Ecad, and RUNX3 genes changed respectively 7, 3.5, 
and 0.25 fold in differentiated cells compared with CB-
HSCs. Figure 3 and figure 4 indicate normalized values 
and calibrated values for gene expression, respectively. 
 
Methylation Specific PCR results 
After bisulfite treatment MSP reaction was performed 
and the products were resolved on a 1.5% agarose gel. 
Product size for the three genes was according to bellow. 
 
 
Figure 1. PCR analysis of CD71 and CD 235 cDNAs from CB-
HSCs and differentiated cells. The patterns revealed sharp bands 
for the products related to differentiated cells. 1a and 1b lines 
indicate cDNAs from CB-HSCs. 2a and 2b lines indicate cDNAs 
from differentiated cells. 
 
Figure 2. CD71 surface marker analysis by flow cytometry. (A) 
Staining of differentiated cells with isotype matched control 
labeled to FITC. (B) CD71 expression after EPO mediated 
erythroid differentiation in cells conjugated to FITC. (C) 
Histogram showing 81% expression of CD71 surface marker on 
differentiated cells. 
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1) Methylated vHL Gene – 158 bp 
2) Unmethylated vHL Gene – 165 bp 
3) Methylated RUNX3 Gene – 130 bp 
4) Unmethylated RUNX3 Gene – 130 bp 
5) Methylated E-Cad Gene – 168 bp 
6) Unmethylated E-Cad Gene – 178 bp 
Ecad and RUNX3 genes showed partial methylation 
pattern in differentiated cells which were the same as 
the patterns in CB-HSCs that has been previously 
described
9
.  
The results for VHL genes revealed no amplified of 
methyalted primers and a well amplified pattern for 
unmethylated primers (Figure 5). 
Discussion 
Epigenetics has been introduced as one of the most 
critical regulator for gene expression and is defined 
as the mechanisms by which the gene expression is 
affected but the sequence remain unchanged. It 
should be noted that not all the genes are regulated 
via epigenetic elements but some genes have a 
particular structure that allows them to be controlled 
by these mechanisms. The most delighted epigenetic 
mechanism is DNA methylation. Many vital 
processes including cell and tissue evolution, 
proliferation, apoptosis, and differentiation have been 
reported to be regulated through DNA methylation
10
. 
Among these processes, hematopoietic stem cell 
differentiation is an ideal model to study the 
epigenetic mechanisms
11
. In this study we have 
addressed this issue for VHL, Ecad and RUNX3 
genes as factors contributing in HSC differentiation.  
A body of valuable concepts on tissue formation and 
gene regulation has been presented so far, but many of 
precise mechanisms by which stem cells differentiate 
into specific lineages have yet to be fully determined. 
Currently it has been deciphered that stem cell 
commitment into specialized cell lineages is mainly 
controlled via gene expression level which in turn can 
be regulated by transcription factors, cell cycle 
regulators, and signaling pathways
12-15
. 
Three of these regulators are VHL, Ecad, and RUNX3 
that assumed to control hematopoietic stem cell 
differentiation into erythroid lineage have been 
evaluated in present study. Having sufficient CpG 
islands in their promoter region, these factors are 
potentially supposed to be regulated by DNA 
methylation during erythroid differentiation. VHL 
protein is a regulator for self-renewing capacity and is 
also a tumor suppressor. The VHL gene deletion has 
 
 
Figure 3. Normalized values of gene expression for VHL, Ecad 
and RUNX3 genes before and after EPO mediated erythroid 
differentiation. 
 
 
 
Figure 4. Calibrated ratios of gene expression for VHL, Ecad and 
RUNX3 genes before and after EPO mediated erythroid 
differentiation. 
 
 
 
Figure 5. Methylation specific PCR results indicate the patterns 
for methyalted and unmethylated forms of VHL, Ecad and 
RUNX3 genes. The wells marked by U letter represent the 
reaction in which unmethylated primers have been applied and 
those which marked with M letter represent the reactions with 
methyalted primers. N-C and P-C indicate the negative and 
positive control, respectively. 
 
Ineffectiveness of Methylation in Rgulation of VHL, ECAD, and RUNX3 genes…                                            Azad et al. 
NBM 61 Novelty in Biomedicine 2015, 2, 57-62 
been reported in a wide spectrum of malignancies
16
. 
Runx3 is also a tumor suppressor agent and a 
transcription factor which controls the differentiation 
process of many cells. Runx3 has an essential role in 
cell cycle regulation by binding to specific promoter 
sequence of cell cycle regulator genes
17
. This factor 
has also a well-known role in differentiation of 
hematopoietic stem cells into thymocytes
10
. Ecad 
protein is an intracellular adhesion molecule which 
can thereby affects cell differentiation
18
. Ecad role in 
hematopiesis was introduced and confirmed in 
1995
10
. The factors have a key role in regulating the 
HSC proliferation and self-renewing capacity, 
erythroblastic island formation in bone marrow, and 
HSC multi lineage differentiation
10
. These genes 
have a special promoter structure which may allow 
them to be controlled by epigenetic mechanisms (like 
methylation) without sequence alteration. In fact 
CpG islands rich promoter can be transcriptionally 
active or silent which is potentially determined by 
methylation
10
. As mentioned earlier, another criterion 
for selecting these genes is their putative role in HSC 
lineage specification.  
Present study has covered the expression levels and 
methylation status of VHL, Ecad, and RUNX3 genes 
and a possible correlation between these two 
parameters after EPO mediated erythroid 
differentiation. We utilized EPO to differentiate the 
CB-HSCs into erythroid lineage in vitro and the cells 
were differentiated successfully, which confirms the 
efficacy of EPO during erythroid differentiation. 
High level expression of CD71 surface marker 
detected on differentiated cells substantiated the 
effectiveness of EPO not only in upregulation of 
CD71 gene (as a determinant of erythroid lineage) in 
transcriptional level, but also in translational stage of 
the CD71 mRNA. 
Expression of VHL gene was in a high level in both 
pre and post differentiation stages which suggests the 
critical role of this gene in both stages. Ecad has a 
significant promotion of expression level in 
differentiated cells which suggests a much more 
important function of this factor in differentiated 
cells compared with CB-HSCs. The results for 
RUNX3 genes showed a decreased expression after 
differentiation by EPO.  
We revealed the unsteady expression level for all the 
three genes before and after differentiation while the 
methylation status remained unchanged. These results 
suggest that although all the three genes have a 
potential of being regulated by promoter methylation 
but it is appear that methylation is not a potent 
mechanism to control these genes during erythroid 
differentiation. It is valuable to note considering that 
the MSP method is not able to disclose subtle 
differences in methylation quantity it is possible that 
there may be a little change in the DNA methylation 
which have not been detected via this method. 
Conduction of a well-established quantitative analysis 
for methylation status (eg. Bisulfite sequencing) is 
recommended to discover the real correlation between 
the methylation status and gene expression. We can 
also assume that other probable mechanisms such as 
loss of heterogeneity, protein mislocalization, and 
histone modification may be involved in controlling 
these genes during erythroid differentiation that 
required further investigations. 
Conclusion 
Significant upregulation of VHL and Ecad genes and a 
comparative downregulation for RUNX3 gene in 
erythroid lineage compared with CB-HSCs along with 
the unchanged methylation pattern suggest other 
controlling mechanisms or incapability of MSP 
method to detect the subtle changes in DNA 
methylation. 
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